Hemogenyx Pharmaceuticals PLC Cash Flow Quality Index

Latest as of June 2016: -2.34x

Hemogenyx Pharmaceuticals PLC cash flow quality index. Hemogenyx Pharmaceuticals PLC (HEMO) has a Cash Flow Quality Index of -2.34x as of June 2016. Operating cash flow of GBX-164.90K is below net income of GBX70.50K, suggesting accrual-heavy earnings not yet converted to cash. See Hemogenyx Pharmaceuticals PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-2.34x
Operating CF / Net Income

Operating Cash Flow

GBX-164.90K
GBX

Net Income

GBX70.50K
GBX

Data as of

Jun 2016
Most recent filing

Hemogenyx Pharmaceuticals PLC Cash Flow Quality Index by Year (None–None)

Hemogenyx Pharmaceuticals PLC cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Hemogenyx Pharmaceuticals PLC. For the full cash flow conversion analysis, see how efficiently does Hemogenyx Pharmaceuticals PLC generate cash.

Year Quality Index Operating CF (GBX) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.